2025
Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma
MEIJS-HERMANNS, Puk; Henrica M J WERNER; Loes KOOREMAN; Petra BRETOVÁ; Vít WEINBERGER et al.Základní údaje
Originální název
Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma
Autoři
MEIJS-HERMANNS, Puk; Henrica M J WERNER; Loes KOOREMAN; Petra BRETOVÁ; Vít WEINBERGER; Stephanie VREDE; Luthy S M ALCALA; Frederic AMANT; Jasmin ASBERGER; Markéta BEDNAŘÍKOVÁ; Dorry BOLL; Carolien M BRONKHORST; Johan BULTEN; Antonio GIL-MORENO; Ingfrid S HALDORSEN; Jitka HAUSNEROVÁ; Jutta HUVILA; Martin KOSKAS; Camilla KRAKSTAD; Heidi KUESTERS-VANDEVELDE; Gemma Mancebo MORENO; Xavier MATIAS-GUIU; Huy NGO; Brenda M PIJLMAN; Maria SANTACANA; Marieke SMINK; Jone TROVIKO; Viola M J VERHOEF; Koen VAN DE VIJVER; van Hamont DENNIS; Anneke A M VAN DER WURFF; Johanna M A PIJNENBORG a Nicole C M VISSER
Vydání
International journal of gynecological cancer, LONDON, BMJ PUBLISHING GROUP, 2025, 1048-891X
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.700 v roce 2024
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/25:00142321
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Endometrioid Endometrial Carcinoma; p53; Progesterone Receptor; Grade 2
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 20. 10. 2025 14:29, Mgr. Tereza Miškechová
Anotace
V originále
Objective: This study aimed to evaluate the association between pre-operative progesterone receptor (PR) and p53 expression and prognosis in pre-operative grade 2 endometrioid endometrial carcinoma compared with grade 1 and grade 3 carcinomas. Methods: Three European endometrial carcinoma cohort studies were included. Patients with pre-operative grade 2 endometrioid carcinoma and known pre-operative PR and p53 status were included (n = 400), as were patients with pre-operative grade 1 (n = 602) or grade 3 (n = 148) endometrioid carcinomas. Kaplan-Meier and Cox regression analyses were performed to analyze disease-specific and disease-free survival. Results: Patients with pre-operative grade 2 endometrial carcinoma and wild-type p53 plus PR-positive expression showed a similar 7-year disease-specific survival to grade 1 endometrial carcinoma patients (95.8% vs 97.5%, p = .13), while the 7-year disease-specific survival of patients with grade 2 endometrial carcinoma with p53 aberrant and/or negative PR expression (83.5%) was significantly lower (p < .001). The combination of these markers was an independent prognostic factor in multivariate Cox regression analyses. Conclusions: The prognostic impact of pre-operative p53 and PR expression in patients with grade 2 endometrioid endometrial carcinoma supports a modified binary grading system in which grade 2 patients should be pre-operatively classified as low-or high-grade depending on p53 and PR expression.